Clinical Trial Update: MK0928 Study in Adult Patients With Primary Insomnia (0928-040)(COMPLETED) [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial of MK0928 for adults with primary insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• MK0928

Snippet

Sponsor: H. Lundbeck A/S | Conditions: Primary Insomnia | Phase 2 | Status: COMPLETED